文献速递内脏/肾动脉与血管畸形

肾动脉支架置入挽救肾功能可改善长期生存

Renal Salvage with Renal Artery Stenting Improves Long-term Survival.
PubMed 文献 · Ann Vasc Surg · 2017-06-07

该单中心回顾性研究纳入60例3期及以上慢性肾脏病合并肾动脉闭塞性疾病患者,按术后eGFR较基线改善至少20%分为应答者与非应答者。中位随访35个月时16例(26.7%)为应答者,应答者长期生存优于非应答者(P=0.046),肾功能改善是长期生存的唯一显著预测因素(HR=0.235,95%CI 0.075-0.733,P=0.0126)。

要点

  • 肾动脉支架术后eGFR改善≥20%的应答者长期生存更优
  • 肾功能改善是长期生存的唯一显著预测因素(HR=0.235)
  • 结果为反对既往阴性试验(如CORAL)提供重要论据

核心结论

  • 肾动脉支架置入成功挽救肾功能与长期生存改善相关。
  • 该数据为既往认为肾动脉支架无益的阴性临床试验提供了重要反驳论据。

研究设计与样本

  • 单中心回顾性研究,纳入60例3期或更差慢性肾脏病合并肾动脉闭塞性疾病并接受肾动脉支架置入以挽救肾功能的患者。
  • 按术后eGFR较基线改善至少20%分为应答者,其余为非应答者;采用Kaplan-Meier法分析生存,Cox比例风险回归识别长期生存预测因素。

主要发现

  • 队列中位年龄66岁(IQR 60-73),术前中位eGFR为34 mL/min/1.73 m2(IQR 24-45)。
  • 中位随访35个月(IQR 22-97个月)时,60例中16例(26.7%)为应答者,术后eGFR中位升高40%(IQR 21-67)。
  • 应答者长期生存优于非应答者(log-rank检验P=0.046)。
  • Cox回归显示肾动脉支架术后肾功能改善是长期生存增加的唯一显著预测因素(HR=0.235,95%CI 0.075-0.733;肾功能改善与恶化的比较P=0.0126)。

临床怎么用

  • 对3期及以上慢性肾脏病合并肾动脉闭塞性疾病患者,肾动脉支架置入后若eGFR较基线改善至少20%,提示长期生存可能获益。

局限性

  • 单中心回顾性研究,样本量60例,结论需更大规模研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) Trial cast doubt on the benefits of renal artery stenting (RAS). However, the outcomes for patients with chronic kidney disease (CKD) were not analyzed separately in the CORAL Trial. We hypothesized that patients who experienced a significant improvement in renal function after RAS would have improved long-term survival, compared with patients whose renal function was not improved by stenting. METHODS: This single-center retrospective study included 60 patients with stage 3 or worse CKD and renal artery occlusive disease who were treated with RAS for renal salvage. Patients were categorized as "responders" or "nonresponders" based on postoperative changes in estimated glomerular filtration rate (eGFR) after RAS. "Responders" were those patients with an improvement of at least 20% in eGFR over baseline; all others were categorized as "nonresponders." Survival was analyzed using the Kaplan-Meier method. Cox proportional hazards regression was used to identify predictors of long-term survival. RESULTS: The median age of the cohort was 66 years (interquartile range [IQR], 60-73). Median preoperative eGFR was 34 mL/min/1.73 m2 (IQR, 24-45). At late follow-up (median 35 months, IQR, 22-97 months), 16 of 60 patients (26.7%) were categorized as "responders" with a median increase in postoperative eGFR of 40% (IQR, 21-67). Long-term survival was superior for responders, compared with nonresponders (P = 0.046 by log-rank test). Cox proportional hazards regression identified improved renal function after RAS as the only significant predictor of increased long-term survival (hazard ratio = 0.235, 95% confidence interval = 0.075-0.733; P = 0.0126 for improved versus worsened renal function after RAS). CONCLUSIONS: Successful salvage of renal function by RAS is associated with improved long-term survival. These data provide an important counter argument to the prior negative clinical trials that found no benefit to RAS.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Modrall JG, Trimmer C, Tsai S, et al. Renal Salvage with Renal Artery Stenting Improves Long-term Survival. Ann Vasc Surg. 2017. PMID: 28602899. doi:10.1016/j.avsg.2017.05.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。